Peter Borchmann

Peter Borchmann is Assistant Medical Director in the Department of Hematology/Oncology at the University Hospital of Cologne. He is head of the lymphoma program in this department and Co-Chairman of the German Hodgkin Study Group (GHSG). His clinical research is based on investigator initiated clinical studies from phase 1 to phase 3. His scientific career is focused on immunotherapy of B-cell malignancies. His group has been selected to conduct the first pivotal CAR T-cell trial in Germany. He is member of different national and international organizations (DGHO; EHA; ASH).